Categories: News

McKesson Ventures Expands Portfolio Development Team and Invests in Market Research

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Lizzie Lee joins McKesson Ventures as Senior Director

SAN FRANCISCO–(BUSINESS WIRE)–McKesson Ventures, the venture capital arm of McKesson Corporation, continues to grow its team, adding Lizzie Lee as its newest member. Lee joins McKesson Ventures as senior director, leading portfolio development and market research for the firm.

With a decade of healthcare experience, Lee is well-positioned to help McKesson Ventures’ portfolio companies scale by developing and facilitating collaboration among the portfolio company, McKesson’s business units and customers. Additionally, Lee will lead market research efforts to further develop McKesson Ventures’ thought leadership on relevant, emerging trends.

“I’m passionate about connecting the innovation of novel startups with the power of industry knowledge, market research and experience,” said Lee. “Joining the McKesson Ventures team is the perfect avenue to move McKesson’s innovation agenda forward and foster the efforts of our portfolio companies.”

Lee joined McKesson Corporation in 2017 and most recently served as a director on the enterprise strategy team where she played an important role in the development and launch of McKesson’s multi-year strategy.

Previously, Lee was a consultant at professional services firm, ZS Associates, where she worked with top pharmaceutical companies on go-to-market strategy, launch planning and market access. Lee also had a significant role in building the company’s innovation team.

“McKesson Ventures is committed to supporting our companies beyond capital funding and having a dedicated team focused on identifying commercial synergies is one of the primary ways we accomplish this,” said Jennifer Carter, partner and vice president, McKesson Ventures. “Lizzie’s deep McKesson expertise and overall healthcare knowledge will be instrumental in developing our portfolio companies.”

Lee is joining McKesson Ventures at an exciting time as it recently completed investments in a variety of startups including, Clinical Ink, Lambert Vet Supply and Koneksa Health. These latest investments and team growth reflect McKesson Ventures’ ongoing commitment to build a diverse leadership team and expand its presence and expertise in oncology care, consumer health, digital pharmacy, biopharma clinical and commercial services, data and analytics and value-based care.

About McKesson Ventures

McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early and growth stage health technology and healthcare services companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. healthcare landscape. McKesson Corporation is a global healthcare company dedicated to making the business of healthcare run better. Visit www.mckessonventures.com to learn more.

Contacts

Sunny Rodriguez

mediarelations@mckesson.com

Staff

Recent Posts

NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING

HOUSTON, June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

4 hours ago

Sony, SCREEN, and VitroVo to Start Trial Offer of MEA System Capable of Simultaneous Measuring and Recording Data from Approximately 237,000 Electrodes

Contributing to high-definition visualization of cellular activity and supporting research into neuronal and cardiac diseases…

4 hours ago

PAIG AI Rebrands as Trust3 AI to Lead the Way in Trusted AI Adoption

SAN FRANCISCO, June 2, 2025 /PRNewswire/ -- PAIG AI, a leading provider of AI governance…

4 hours ago

Delivra Health Brands, and Its Dream Water(R) Brand, Partners with QVC to Bring Dream Water to Online Shoppers Across the US

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB:…

11 hours ago

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company")…

14 hours ago

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical…

16 hours ago